Are there contraindications or additive side effects when combining bupropion (Wellbutrin) with memantine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Absolute Contraindications Between Wellbutrin and Memantine

The combination of bupropion (Wellbutrin) and memantine can be used together safely, as there are no absolute contraindications and no clinically significant pharmacokinetic interactions between these medications. 1, 2

Evidence from FDA Drug Labels

The FDA label for memantine explicitly addresses this combination, stating that memantine did not affect the pharmacokinetics of bupropion (a CYP2B6 substrate) or its metabolite hydroxybupropion 2. This is critical because it demonstrates no metabolic interference between the two drugs.

The Wellbutrin FDA label does not list memantine as a contraindicated medication or as requiring special precautions 1. The major contraindications for bupropion are:

  • MAO inhibitors (absolute contraindication)
  • Seizure disorders
  • Bulimia/anorexia nervosa
  • Abrupt discontinuation of alcohol or benzodiazepines

Theoretical Considerations

While there are no direct contraindications, be aware of these clinical nuances:

Seizure Risk

Bupropion lowers the seizure threshold in a dose-dependent manner 1. However, memantine does not appear in the literature as a drug that significantly affects seizure threshold. Monitor patients on higher doses of bupropion (>450 mg/day immediate-release or >400 mg/day sustained-release), but memantine does not add meaningful seizure risk.

Dopaminergic Effects

Bupropion has dopamine reuptake inhibition properties 3, 4. The Wellbutrin label specifically warns about combining with other dopaminergic drugs like amantadine and levodopa, which can cause CNS toxicity (restlessness, agitation, tremor, ataxia, gait disturbance, vertigo, dizziness) 1.

Memantine is NOT listed among these dopaminergic drugs requiring caution in the FDA label, and the pharmacology differs substantially—memantine is an NMDA receptor antagonist, not a direct dopamine agonist 2, 5.

Clinical Use in Practice

This combination is actually used therapeutically:

  • Memantine is commonly prescribed for moderate-to-severe Alzheimer's disease 6, 7, 8
  • Bupropion is used for depression, including in patients with dementia who have comorbid depression 9, 4
  • Research shows memantine can be combined with antidepressants safely 9

Common Pitfalls to Avoid

  1. Don't confuse memantine with amantadine: Amantadine requires caution with bupropion due to dopaminergic effects; memantine does not share this concern
  2. Monitor for additive CNS effects: Both drugs can cause dizziness, headache, and confusion independently—watch for cumulative effects but these are manageable, not contraindications
  3. Renal dosing for memantine: Adjust memantine dose in severe renal impairment (CrCl 5-29 mL/min) 2, but this doesn't interact with bupropion dosing

Bottom Line

Prescribe both medications together when clinically indicated without dose adjustments. The pharmacokinetic study data directly supports safety of this combination 2. Monitor for typical side effects of each drug individually (nausea, dizziness, headache), but expect no synergistic toxicity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.